Acupressure in Hospitalized Patients

Randomized Controlled Trial of Acupressure to Improve Patient Satisfaction and Quality of Recovery in Hospitalized Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02762435

Enrollment

200

Registered

2016-05-05

Start date

2016-03-31

Completion date

2017-01-31

Last updated

2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupressure

Brief summary

After written informed consent eligible hospitalized patients will be randomized to one of 3 arms (1:1:1:): control, sham, accupressure (3 points on the hand and wrist three times per day). Quality of recovery and other measures of patient satisfaction will be recorded.

Detailed description

After written informed consent eligible hospitalized patients will be randomized to one of 3 arms (1:1:1:): control (no touch), sham (light touch), acupressure (2 minutes moderate pressure each at PC6, LI4, and HT7 three times per day). Quality of recovery using the validated Quality of Recovery (QOR) 15 score and other measures of patient satisfaction (nausea score, pain score) will be recorded at baseline and after their 6 study sessions.

Interventions

OTHERsham

light touch at established points on hand and wrist

OTHERcontrol

no contact with the subject

OTHERacupressure

moderate pressure at established points on hand and wrist

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. adults 2. patients at Stony Brook hospital 3. expected to be hospitalized for at least 3 days 4. able to sign informed consent and participate in the study

Exclusion criteria

1. Under 18 years of age 2. Do not have access to the 3 points on the hand and wrist due to skin breakdown, ulcers, cellulitis, broken bone, indwelling catheter within 5 cm radius of the pressure points. 3. Significant dementia or altered mental status that would prevent assessment of the QOR survey 4. Allergic reaction to ink 5. Stroke or other neurologic condition which precludes sensation in both upper extremities. 6. Ongoing use of regional anesthetic technique 7. Pregnancy

Design outcomes

Primary

Measure	Time frame	Description
Change in Quality of Recovery score	Time Frame: Day 0, Day 2	The validated QOR15 score will be assessed at baseline (Day 0) and after the 6 sessions have been completed (Day 2) and the change in QOR15 (Day 2 minus Day 0) will be calculated.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026